Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition

Full text
Author(s):	Versailles, Jacques B. E. ; Metelus, Sherly ; Peloggia, Alessandra ; Laporte, Montas ; Bahamondes, Luis ; Juliato, Cassia Total Authors: 6
Document type:	Journal article
Source:	EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE; v. 28, n. 4, p. 3-pg., 2023-05-27.
Abstract
Objectives: To assess perimenopausal users of 52mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause. Material and methods: a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use. Results: Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms. Conclusion: Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms. SHORT CONDENSATION The 52mg hormonal-IUD who were at menopausal transition reported worries that the use of the IUD can affect menopausal symptoms. It is important that health professionals can routinely guide these women. (AU)

FAPESP's process:	15/20504-9 - Clinical findings among progestin-only contraceptives' users
Grantee:	Luis Guillermo Bahamondes
Support Opportunities:	Research Projects - Thematic Grants